News Centre

BIS: Ripple Effects Of Monetary Policy

Date 06/08/2021

Summary

Focus

When a firm cannot easily substitute financially constrained clients or suppliers in the face of an adverse monetary policy shock, the fall in demand or supply may create bottlenecks and induce the firm to cut back its activity. We refer to this as the "ripple effects" of monetary policy. This paper studies how conventional monetary policy transmits through the demand and supply of intermediate goods and the role of input-output linkages as transmission channels.

ESMA Publishes Its Report On The Use Of FinTech By CSDs

Date 06/08/2021

The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, has today published its Report on the use of FinTech by Central Securities Depositories (CSDs).

Moscow Exchange: Risk Parameters Change For The Securities

Date 06/08/2021

The following risk parameters will be changed:

Bitfinex Launches BIT Mode On Satoshi

Date 06/08/2021

Bitfinex, a state-of-the-art digital token trading platform, has made BIT Mode on Satoshi available to the exchange’s user base, enabling customers to divide their holdings into the smallest units of a bitcoin.

Ulisse Biomed S.p.A. Lists On AIM Italia

Date 06/08/2021

• Twenty–second listing of 2021 on Borsa Italiana’s AIM Italia

• Ulisse Biomed S.p.A. brings the total number of companies listed on Borsa Italiana’s AIM Italia to 153

• Total placement volume of the offering equal to €5 million with listing

Borsa İstanbul’s Opening Bell Rang For Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

Date 06/08/2021

In his address at the opening bell ceremony, Borsa İstanbul CEO Korkmaz Ergun contended as follows:

“Ladies and gentlemen, I welcome you all to the ceremony held for the Initial Public Offering (IPO) of Gen İlaç. First of all, due to the forest fire we are facing, I would like to express that we stand by all of our officers and people who are struggling with full effort as Borsa İstanbul. I wish God's mercy on those who lost their lives and a speedy recovery to all the injured. Gen İlaç makes us all proud in the pharmaceutical industry with its qualified product and service approach. Once again, it has been understood during the pandemic that the breakthroughs of our companies such as Gen İlaç will continue to carry our country a step further in this strategically important sector. Thus, the place and significance of Gen İlaç in the sector and its accomplishments in its activities also resonate with the success of the IPO. Gen İlaç launched a successful IPO with an amount of approximately 738 million TL and sales to 49 thousand investors.

SEC Charges Decentralized Finance Lender And Top Executives for Raising $30 Million Through Fraudulent Offerings - Case Is Agency’s First Involving Securities Using DeFi Technology

Date 06/08/2021

The Securities and Exchange Commission today charged two Florida men and their Cayman Islands company for unregistered sales of more than $30 million of securities using smart contracts and so-called “decentralized finance” (DeFi) technology, and for misleading investors concerning the operations and profitability of their business DeFi Money Market.  

Moscow Exchange: Risk Parameters Change For The Security CHRW-RM

Date 06/08/2021

As per the Securities market risk parameters methodology, on 06.08.2021, 15-49 (MSK) the upper bound of the price band (up to 7482) and initial margins (up to 21 %) for the security CHRW-RM were changed. New values are available here

Euronext Announces Volumes For July 2021

Date 06/08/2021

Euronext, the leading pan-European market infrastructure, today announced trading volumes for July 2021.

Closure Of Bursa Malaysia In Conjunction With Awal Muharram 2021

Date 06/08/2021

Bursa Malaysia Berhad and its subsidiaries will be closed on Tuesday, 10 August 2021, in conjunction with Awal Muharram.